Expecting CD20-positive B-cells to differentiate towards plasma cells, future studies may utilize double staining for a CD20 and a plasma cell marker to elucidate the amount and prognostic impact of plasma cells in invasive penile squamous cell carcinomas of the penis to further provide evidence for anti-PD-L1 therapies. This evidence concerns the gene CD274 and squamous cell carcinoma.